In vivo PET measurements with [11C]PE2I to evaluate fetal mesencephalic transplantations to unilateral 6-OHDA-lesioned rats

Cell Transplantation

Volumn 14, Issue 9, 2005, Pages 655-663

  Inaji, Motoki ^a,b   Yoshizaki, Takahito ^c,e   Okauchi, Takashi ^a   Maeda, Jun ^a   Nagai, Yuji ^a   Nariai, Tadashi ^b   Ohno, Kikuo ^b   Ando, Kiyoshi ^d   Okano, Hideyuki ^c,d   Obayashi, Shigeru ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Central Institute for Experimental Animal   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

6 Hydroxydopamine (6 OHDA); Dopamine transporter; PE2I; PET; Transplantation

Indexed keywords

CARBON 11; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; N (3 IODOPROP 2 ENYL) 2BETA CARBOMETHOXY 3BETA (4' METHYLPHENYL)NORTROPANE C 11; NORTROPANE DERIVATIVE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTORADIOGRAPHY; CELL SURVIVAL; CELL TRANSPLANTATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC TRANSMISSION; FETAL MESENCEPHALON TRANSPLANTATION; FETUS; FETUS CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MEASUREMENT; MESENCEPHALON; NERVE CELL; NERVE CELL TRANSPLANTATION; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STRATUM CORNEUM; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CELL TRANSPLANTATION; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NORTROPANES; OXIDOPAMINE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 30144432772     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783982684     Document Type: Conference Paper

References (30)

1. Annett, L. E.; Martel, F. L.; Rogers, D. C.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. Behavior assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246; 1994.
2. Betchen, S. A.; Kaplitt, M. Future and current surgical therapies in Parkinson's disease. Curr. Opin. Neurol. 16(4): 487-493; 2003.
3. Bjorklund, L. M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I. Y.; McNaught, K. S.; Brownell, A. L.; Jenkins, B. G.; Wahlestedt, C.; Kim, K. S.; Isacson, O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 99:2344-2349; 2002.
4. 11C-raclopride and positron emission tomography. Ann. Neurol. 31:184-192; 1992.
5. Brooks, D. J.; Piccini, P. Non-invasive in vivo imaging of transplant function. Prog. Brain Res. 127:321-332; 2000.
6. Brownell, A. L.; Livni, E.; Galpern, W.; Isacson, O. In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants. Ann. Neurol. 43:387-390; 1998.
7. Chalon, S.; Garreau, L.; Emond, P.; Zimmer, L.; Vilar, M. P.; Besnard, J. C.; Guilloteau, D. Pharmacological characterization of (E)-N-(3-iodoprop-2- enyl)-2beta-carbomethoxy-3beta-(4′-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter. J. Pharmacol. Exp. Ther. 291:648-654; 1999.
8. Chen, N.; Reith, M. E. Structure and function of the dopamine transporter. Eur. J. Pharmacol. 405:329-339; 2000.
9. Chen, Y. I.; Brownell, A. L.; Galpern, W.; Isacson, O.; Bogdanov, M.; Beal, M. F.; Livni, E.; Rosen, B. R.; Jenkins, B. G. Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. Neuroreport 10:2881-2886; 1999.
10. Fine, A.; Hunt, S. P.; Oertel, W. H.; Nomoto, M.; Chong, P. N.; Bond, A.; Waters, C.; Temlett, J. A.; Annett, L.; Dunnett, S. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Prog. Brain Res. 78:479-489; 1988.
11. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719; 2001.
12. Guilloteau, D.; Emond, P.; Baulieu, J. L.; Garreau, L.; Frangin, Y.; Pourcelot, L.; Mauclaire, L.; Besnard, J. C.; Chalon, S. Exploration of the dopamine transporter: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)- 2beta-carbomethoxy-3beta-(4′-m ethylphenyl)nortropane (PE2I). Nucl. Med. Biol. 25:331-337; 1998.
13. Hagell, P.; Schrag, A.; Piccini, P.; Jahanshahi, M.; Brown, R.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Odin, P.; Wenning, G. K.; Morrish, P.; Gustavii, B.; Björklund, A.; Brooks, D. J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 122:1121-1132; 1999.
14. Hauser, R. A.; Freeman, T. B.; Snow, B. J.; Nauert, M.; Gauger, L.; Kordower, J. H.; Olanow, C. W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56:179-187; 1999.
15. Lammertsma, A. A.; Hume, S. P. Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158; 1996.
16. Lindvall, O. Stem cells for cell therapy in Parkinson's disease. Pharmacol. Res. 47:279-287; 2003.
17. Murayama, A.; Matsuzaki, Y.; Kawaguchi, A.; Shimazaki, T.; Okano, H. Row cytometric analysis of neural stem cells in the developing and adult mouse brain. J. Neurosci. Res. 69:837-847; 2002.
18. Nishino, H.; Hashitani, T.; Kumazaki, M.; Sato, H.; Furuyama, F.; Isobe, Y.; Watari, N.; Kanai, M.; Shiosaka, S. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res. 534:83-93; 1990.
19. Okano, H. Stem cell biology of the central nervous system. J. Neurosci. Res. 69:698-707; 2002.
20. Okano, H.; Yoshizaki, T.; Shimazaki, T.; Sawamoto, K. Isolation and transplantation of dopaminergic neurons and neural stem cells. Parkinsonism Relat. Disord. 9:23-28; 2002.
21. Olanow, C. W.; Watts, R. L.; Koller, W. C. An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines. Neurology 56:S1-S88; 2001.
22. Piccini, P. P. Dopamine transporter: Basic aspects and neuroimaging. Mov. Disord. 18:83-8; 2003.
23. Rinne, U. K.; Laihinen, A.; Rinne, J. O.; Nagren, K.; Bergman, J.; Ruotsalainen, U. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Mov. Disord. 5:55-59; 1990.
24. Riederer, P.; Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J. Neural Transm. 38:277-301; 1976.
25. 11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: Suppression of its radiolysis. Int. J. Rad. Appl. Instrum. [A] 41: 593-599; 1990.
26. 11C]Ro-15-4513. J. Label. Compound Radiopharm. 42:8129-8131; 1999.
27. Tabbal, S.; Fahn, S.; Frucht, S. Fetal tissue transplantation in Parkinson's disease. Curr. Opin. Neurol. 11:341-349; 1998.
28. Tatsch, K. Imaging of the dopaminergic system in parkinsonism with PET. Nucl. Med. Commun. 22:819-827; 2001.
29. Thobois, S.; Guillouet, S.; Broussolle, E. Contribution of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. Neurophysiol. Clin. 31:321-340; 2001.
30. Wenning, G. K.; Odin, P.; Morrish, P.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Brown, R.; Gustavii, B.; Hagell, P.; Jahanshahi, M.; Sawle, G.; Björklund, A.; Brooks, D. J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:95-107; 1997.